Rising incidence of clinically evident Barrett's oesophagus in The Netherlands: A nation-wide registry of pathology reports

Scandinavian Journal of Gastroenterology

Volumn 42, Issue 1, 2007, Pages 17-22

  Post, Piet N ^a   Siersema, Peter D ^b   Van Dekken, Herman ^b  

^a Prismant Health Care and Advise Institute   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Adenocarcinoma; Barrett's oesophagus; Cancer of the oesophagus; Endoscopy; Epidemiology; Gastrointestinal; Histopathology; Incidence

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BARRETT ESOPHAGUS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CONFIDENCE INTERVAL; ENDOSCOPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS BIOPSY; FEMALE; HEALTH SURVEY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRECANCER; PRIORITY JOURNAL; SEX RATIO; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; TISSUE SECTION;

ADENOCARCINOMA; AGED; BARRETT ESOPHAGUS; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NETHERLANDS;

EID: 33845917254     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520600815654     Document Type: Article

References (20)

1. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF, Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-9.
2. Devesa SS, Blot WJ, Fraumeni JF, Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049-53.
3. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985;313:857-9.
4. Hage M, Siersema PD, van Dekken H, Steyerberg EW, Dees J, Kuipers EJ. Oesophageal cancer incidence and mortality in patients with long-segment Barrett's oesophagus after a mean follow-up of 12.7 years. Scand J Gastroenterol 2004;39:1175-9.
5. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-31.
6. Prach AT, MacDonald TA, Hopwood DA, Johnston DA. Increasing incidence of Barrett's oesophagus: education, enthusiasm, or epidemiology? Lancet 1997;350:933.
7. Conio M, Cameron AJ, Romero Y, Branch CD, Schleck CD, Burgart LJ, et al. Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota. Gut 2001;48:304-9.
8. Cote RA, Robboy S. Progress in medical information management. Systematized nomenclature of medicine (SNOMED). JAMA 1980;243:756-62.
9. Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002;97:1888-95.
10. Sharma P, McQuaid K, Dent J, Fennerty MB, Sampliner R, Spechler S, et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology 2004;127:310-30.
11. Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol 1994;25:982-93.
12. van Dekken H. Histopathology of Barrett's esophagus. In: Tilanus HW, Attwood SEA, editors. Barrett's esophagus. Dordrecht: Kluwer Academic Publishers; 2001. pp 159-67.
13. Breslow NE, Day NE. Indirect standardization and multiplicative models for rates, with reference to the age adjustment of cancer incidence and relative frequency data. J Chronic Dis 1975;28:289-303.
14. el Serag HB, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut 1998;43:327-33.
15. Numans ME, De Wit NJ, Dirven JA, Hurenkamp GJ, Meijer QC, Muris JW, et al. NHG guideline stomach complaints. 2nd revision in Dutch. Huisarts Wet 2003;46:690-700.
16. Eisen GM, Sandler RS, Murray S, Gottfried M. The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. Am J Gastroenterol 1997;92:27-31.
17. Lieberman DA, Oehlke M, Helfand M. Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy. Am J Gastroenterol 1997;92:1293-7.
18. van Sandick JW, Bartelsman JF, van Lanschot JJ, Tytgat GN, Obertop H. Surveillance of Barrett's oesophagus: physicians' practices and review of current guidelines. Eur J Gastroenterol Hepatol 2000;12:111-7.
19. Murray L, Watson P, Johnston B, Sloan J, Mainie IM, Gavin A. Risk of adenocarcinoma in Barrett's oesophagus: population based study. Br Med J 2003;327:534-5.
20. Netherlands Cancer Registry. Age standardized mortality rates (ESR) according to site and year of death for males in 1989-2003 accessed through http://www.ikcnet.nl 28-4-2006.